StockData
Shuttle Pharmaceuticals Holdings, Inc. logo

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock

SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 24, 2026Score 5/30
$4.24−0.29 (-6.40%)

Close on Nov 16, 2026Market cap $4.24MP/E –Yield –

Earnings

Shuttle Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Shuttle Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2025ended Dec 31, 2025Feb 17, 2026during market hours–––Filing
Q4 FY2024ended Dec 31, 2024Feb 26, 2025before the open–––Filing
Q3 FY2024ended Sep 30, 2024Nov 13, 2024during market hours–––Release
Q1 FY2024ended Mar 31, 2024May 14, 2024before the open–––Release
Q4 FY2023ended Dec 31, 2023Mar 22, 2024before the open–––Release
Q3 FY2023ended Sep 30, 2023Nov 14, 2023before the open–––Release
Q2 FY2023ended Jun 30, 2023Aug 15, 2023before the open–––Release
Q1 FY2023ended Mar 31, 2023May 26, 2023before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Shuttle Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Shuttle Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Shuttle Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Update
  3. Update
  4. Update
  5. Update
  6. Update
  7. News
  8. News
  9. News
  10. News
  11. Update
  12. Update
  13. News
  14. News
  15. News

See a number that looks wrong?